Zantac
In October 2019, a class-action lawsuit was filed against Sanofi for allegedly misleadingly marketing the over-the-counter heartburn medication Zantac as safe when, according to plaintiffs, the medicine contains dangerously high levels of the carcinogen N-nitrosodimethylamine (NDMA). (Rodriguez et al v. Sanofi U.S. LLC et al, Case No. 19-cv-9527, S. D. NY.)
Class-Action Tracker
The Latest
MLMs Are Consistently Leaving Participants Behind
New book explores why MLMs are often associated with harmful outcomes – and what can be done about it.
Tubi: Fakin’ It
You don’t need to fake your own death to feel love.
Bytech America’s Made in USA Claims
Marketing and reality are not in sync.
CATrends: Chips Made with Avocado Oil
New study opens the floodgates to class-action litigation.
FTC Takes Decisive Action Against Amway
Agency alleges MLM misled recruits about earnings, pressured distributors to buy products and encouraged fake retail sales.